Exact Sciences: Wait, It’s Not That Bad!
January 17, 2018 at 15:17 PM EST
Exact Sciences is down more than 10% as investors fret about a potential competitor to one of its cancer tests.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.